Pneumococcal disease (IPD)

Pneumococcal vaccine is being added to the Expanded Programme on Immunization under Resolution 104; there are several types: PCV10, PCV13, PCV15, PCV20, PPSV23.

Streptococcus pneumoniae Cause: Bacterium Streptococcus pneumoniae Expanded Programme on Immunization

Transmission

Spread by respiratory droplets when coughing or sneezing, and by direct contact.

Symptoms

Depends on the site: pneumonia (high fever, productive cough, difficulty breathing), middle ear infection (ear pain, discharge), meningitis (stiff neck, seizures, drowsiness).

Complications

Invasive pneumococcal disease (IPD), sepsis, death from septic shock, deafness after meningitis.

People at high risk

Children under 2 years, older adults ≥ 60 years, people with COPD, asthma, heart disease, diabetes, or without a spleen.

Preventive vaccines

Prevenar 13 (PCV13) – 13-valent pneumococcal conjugate vaccine
Synflorix (PCV10) – 10-valent pneumococcal conjugate vaccine
Pneumococcal vaccine (EPI) – Pneumococcal vaccine in the Expanded Programme on Immunization
Prevenar 20 (PCV20) – 20-valent pneumococcal conjugate vaccine
Vaxneuvance (PCV15) – 15-valent pneumococcal conjugate vaccine
Pneumovax 23 (PPSV23) – Multivalent pneumococcal polysaccharide vaccine